WA
GILD icon

Wasatch Advisors’s Gilead Sciences GILD Stock Holding History

Wasatch Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40,950
Closed -$3.07M – 258
2023
Q3 		$3.07M Hold
40,950
– – 0.02% 226
2023
Q2 		$3.16M Hold
40,950
– – 0.02% 226
2023
Q1 		$3.4M Sell
40,950
-9,100
-18% -$754K 0.02% 222
2022
Q4 		$4.3M Hold
50,050
– – 0.03% 206
2022
Q3 		$3.09M Buy
+50,050
New +$3.16M 0.02% 217

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors's GILD Position: Q4 2023 in Review

Wasatch Advisors sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 40,950 shares — an estimated $3.07M sold.

Wasatch Advisors first reported a position in GILD in Q3 2022 and held it in 5 quarters. The position peaked at $4.3M in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Wasatch Advisors reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Wasatch Advisors sold 40,950 Gilead Sciences shares in Q4 2023, an estimated $3.07M.
  • Wasatch Advisors first reported a position in Gilead Sciences in Q3 2022 and held it in 5 quarters.
  • Wasatch Advisors's Gilead Sciences position peaked at $4.3M in Q4 2022.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Wasatch Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.